Background and Aims Carcinoembryonic antigen (CEA) is the most commonly used tumor
marker for gastrointestinal cancers but its value for resectable gastric adenocarcinoma …

Background Circulating biomarkers may be of value in providing additional prognostic
information to the TNM staging system. Previous population‐level studies suggest a …

CONTEXT: Carcinoembryonic antigen (CEA) can be detected in colorectal tumor tissue but
its role in the survival of patients remains controversial. OBJECTIVE: To characterize the …

Methods: Patients with esophageal adenocarcinoma scheduled for chemoradiotherapy
followed by surgery between 1998 and 2014 were selected from a retrospectively collected …

Background: Preoperative carcinoembryonic antigen (CEA) level is considered as a factor
predictive of survival in colorectal cancer patients. Patients with normal (< 5 ng/ml) or lower …

Background Carcinoembryonic antigen (CEA) is the most widely used tumor marker in colon
cancer; however, there has been controversy regarding the significance of preoperative …

Background Recently, a few researches focus on the correlation between postoperative
carcinoembryonic antigen (post-CEA) and the outcome of colorectal cancer (CRC), but none …

BACKGROUND/AIMS: We investigated the role of preoperative and serial postoperative
serum CEA levels in advanced gastric cancer patients with curative operation. MATERIALS …

Carcinoembryonic antigen is an acid glycoprotein, the levels of which may increase in
patients with colorectal carcinoma. The prognostic significance of preoperative …

AIM: To determine whether serum levels of carcinoembryonic antigen (CEA) correlate with
the presence of primary colorectal cancer (CRC), and/or recurrent CRC following radical …